GAD2 and depressive symptom measurement: Repeated injections of corticosterone, which is an animal model of depression, led to alterations in GABAergic and glutamatergic activity, such as the expression of GAD67, GAD65, and several GABAA receptor subunits in the hippocampus and amygdala51.